Authors: Abdullahi T. Aborode, Andrew A. Wireko, Aashna Mehta, Toufik Abdul‐Rahman, Esther P. Nansubuga, Mrinmoy Kundu, Manas Pustake, Qasim Mehmood, H. Tillewein
Year: 2022
Journal: Journal of Medical Virology
DOI: 10.1002/jmv.27745
Summary#
This letter discusses the concern over Nipah virus cases in India during the COVID-19 pandemic and the lack of specific pharmacological treatment for Nipah virus.
Key Findings#
- Nipah virus is a zoonotic infection that can be transmitted by direct contact with infected animals or via bodily secretions such as bat blood, saliva, and urine.
- The virus affects the central nervous system in human hosts, causing inflammation of brain parenchyma (encephalitis) and respiratory symptoms.
- Nipah virus has been designated a global epidemic by the WHO due to its high fatality rate, highly contagious nature, potential for human exposure, and lack of a vaccine.
- The diversity of surroundings and hosts may further accelerate the mutation rate of RNA viruses, explaining new cases in pandemics such as COVID-19.
Methodology#
- Study Type: Letter to the Editor
- Geographic Focus: India
Topics#
Nipah virus, Zoonotic infections, Epidemiology, Public health
Relevance#
The paper highlights the concern over Nipah virus cases in India during the COVID-19 pandemic, which could strain public health resources and necessitate early diagnosis and management.